Salpingo-Oophorectomy Overview

Save information for later
Sign Up

Learn About Salpingo-Oophorectomy

Who are the top Salpingo-Oophorectomy Local Doctors?
Steven A. Narod
Elite in Salpingo-Oophorectomy
Elite in Salpingo-Oophorectomy
790 Bay Street, 
Toronto, ON, CA 

Steven Narod practices in Toronto, Canada. Mr. Narod and is rated as an Elite expert by MediFind in Salpingo-Oophorectomy. His top areas of expertise are Ovarian Cancer, Breast Cancer, BRCA Positive Breast Cancer, Oophorectomy, and Mastectomy.

Susan M. Domchek
Elite in Salpingo-Oophorectomy
Elite in Salpingo-Oophorectomy

University Of Penn-Medical Group

145 Kng Of Prussia Rd 200, Hem Onc Radnor, 
Radnor, PA 
Languages Spoken:
English
Offers Telehealth

Susan Domchek is an Oncologist in Radnor, Pennsylvania. Dr. Domchek and is rated as an Elite provider by MediFind in Salpingo-Oophorectomy. Her top areas of expertise are Breast Cancer, Ovarian Cancer, BRCA Positive Breast Cancer, Salpingo-Oophorectomy, and Hormone Replacement Therapy (HRT).

 
 
 
 
Learn about our expert tiers
Learn More
Elite in Salpingo-Oophorectomy
Elite in Salpingo-Oophorectomy
Charterhouse Square, 
London, ENG, GB 

Ranjit Manchanda practices in London, United Kingdom. Mr. Manchanda and is rated as an Elite expert by MediFind in Salpingo-Oophorectomy. His top areas of expertise are Ovarian Cancer, BRCA Positive Breast Cancer, Endometrial Cancer, Oophorectomy, and Salpingo-Oophorectomy.

What are the latest Salpingo-Oophorectomy Clinical Trials?
Endocrine Therapies With Ovarian Function Suppression in Premenopausal Node+ Early Breast Cancer With Low Genomic Risk (INTERSTELLAR Trial, KBCSG-25)

Summary: Among ER+HER2- premenopausal patients with N1 who undergoes primary breast surgery, we will identify the patients with a genomic low risk using the multigene-assay (OncoFREE®). In these, ovarian function suppression with endocrine therapies including either tamoxifen or aromatase-inhibitors will be administered for 5 years.

Match to trials
Find the right clinical trials for you in under a minute
Get started
A Non-Randomized Prospective Clinical Trial Comparing the Non-Inferiority of Salpingectomy to Salpingo-oophorectomy to Reduce the Risk of Ovarian Cancer Among BRCA1 Carriers [SOROCk]

Summary: This clinical trial evaluates how well two surgical procedures (bilateral salpingectomy and bilateral salpingo-oophorectomy) work in reducing the risk of ovarian cancer for individuals with BRCA1 mutations. Bilateral salpingectomy involves the surgical removal of fallopian tubes, and bilateral salpingo-oophorectomy involves the surgical removal of both the fallopian tubes and ovaries. This study m...